A detailed history of Adar1 Capital Management, LLC transactions in Xencor Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 85,826 shares of XNCR stock, worth $793,890. This represents 0.1% of its overall portfolio holdings.

Number of Shares
85,826
Previous 398,152 78.44%
Holding current value
$793,890
Previous $4.24 Billion 84.08%
% of portfolio
0.1%
Previous 0.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$7.52 - $11.26 $2.35 Million - $3.52 Million
-312,326 Reduced 78.44%
85,826 $675 Million
Q1 2025

May 15, 2025

BUY
$10.64 - $24.13 $1.74 Million - $3.95 Million
163,545 Added 69.71%
398,152 $4.24 Billion
Q4 2024

Feb 13, 2025

SELL
$19.43 - $26.84 $2.09 Million - $2.89 Million
-107,655 Reduced 31.45%
234,607 $5.39 Billion
Q3 2024

Nov 14, 2024

BUY
$15.7 - $21.65 $5.37 Million - $7.41 Million
342,262 New
342,262 $6.88 Billion

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $552M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.